Advertisement
LIVN vs MMSI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIVN is a StrongBuy and MMSI is a StrongBuy.
Momentum Indicator for LIVN turns positive, indicating new upward trend
LIVN saw its Momentum Indicator move above the 0 level on October 15, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned positive. In 66 of the 87 cases, the stock moved higher in the following days. The odds of a move higher are at 76%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for LIVN just turned positive on October 09, 2026. Looking at past instances where LIVN's MACD turned positive, the stock continued to rise in 30 of 47 cases over the following month. The odds of a continued upward trend are 64%.
Following a +2.75% 3-day Advance, the price is estimated to grow further. Considering data from situations where LIVN advanced for three days, in 205 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
LIVN moved below its 50-day moving average on October 21, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LIVN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
LIVN broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for LIVN entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. LIVN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 55 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.261) is normal, around the industry mean (2.923). P/E Ratio (22.736) is within average values for comparable stocks, (2.388). Projected Growth (PEG Ratio) (0.899) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (2.954) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 81 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LIVN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
MMSI in upward trend: price rose above 50-day moving average on October 15, 2026
MMSI moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend. In 29 of 40 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 73%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on MMSI as a result. In 63 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.
The Moving Average Convergence Divergence (MACD) for MMSI just turned positive on October 12, 2026. Looking at past instances where MMSI's MACD turned positive, the stock continued to rise in 25 of 36 cases over the following month. The odds of a continued upward trend are 69%.
The 10-day moving average for MMSI crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Following a +1.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where MMSI advanced for three days, in 197 of 298 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MMSI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.
MMSI broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. MMSI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 56 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 74 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.249) is normal, around the industry mean (4.952). P/E Ratio (37.306) is within average values for comparable stocks, (36.644). Projected Growth (PEG Ratio) (1.574) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (3.273) is also within normal values, averaging (56.876).
The Tickeron Profit vs. Risk Rating rating for this company is 75 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MMSI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
LIVN | MMSI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 81 | 37 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 78 Overvalued | 75 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 75 | |
SMR RATING 1..100 | 55 | 74 | |
PRICE GROWTH RATING 1..100 | 41 | 39 | |
P/E GROWTH RATING 1..100 | 81 | 56 | |
SEASONALITY SCORE 1..100 | 50 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MMSI's Valuation (75) in the Medical Specialties industry is in the same range as LIVN (78). This means that MMSI’s stock grew similarly to LIVN’s over the last 12 months.
MMSI's Profit vs Risk Rating (75) in the Medical Specialties industry is in the same range as LIVN (100). This means that MMSI’s stock grew similarly to LIVN’s over the last 12 months.
LIVN's SMR Rating (55) in the Medical Specialties industry is in the same range as MMSI (74). This means that LIVN’s stock grew similarly to MMSI’s over the last 12 months.
MMSI's Price Growth Rating (39) in the Medical Specialties industry is in the same range as LIVN (41). This means that MMSI’s stock grew similarly to LIVN’s over the last 12 months.
MMSI's P/E Growth Rating (56) in the Medical Specialties industry is in the same range as LIVN (81). This means that MMSI’s stock grew similarly to LIVN’s over the last 12 months.
| LIVN | MMSI | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 2 days ago 68% | 2 days ago 61% |
| Momentum ODDS (%) | 2 days ago 76% | 2 days ago 66% |
| MACD ODDS (%) | 2 days ago 64% | 2 days ago 69% |
| TrendWeek ODDS (%) | 2 days ago 68% | 2 days ago 61% |
| TrendMonth ODDS (%) | 2 days ago 66% | 2 days ago 58% |
| Advances ODDS (%) | 3 days ago 68% | 2 days ago 66% |
| Declines ODDS (%) | 9 days ago 74% | 9 days ago 57% |
| BollingerBands ODDS (%) | 2 days ago 78% | 2 days ago 56% |
| Aroon ODDS (%) | 2 days ago 64% | N/A |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
LIVN’s FA Score shows that 0 FA rating(s) are green while MMSI’s FA Score has 0 green FA rating(s).
- LIVN’s FA Score: 0 green, 5 red.
- MMSI’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
LIVN’s TA Score shows that 3 TA indicator(s) are bullish while MMSI’s TA Score has 5 bullish TA indicator(s).
- LIVN’s TA Score: 3 bullish, 5 bearish.
- MMSI’s TA Score: 5 bullish, 3 bearish.
Price Growth
LIVN (@Medical/Nursing Services) experienced а +3.10% price change this week, while MMSI (@Pharmaceuticals: Other) price change was +4.86% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.74%. For the same industry, the average monthly price growth was -3.62%, and the average quarterly price growth was +9.09%.
Reported Earning Dates
LIVN is expected to report earnings on Nov 04, 2026.
MMSI is expected to report earnings on Oct 29, 2026.
Industries' Descriptions
@Medical/Nursing Services (-1.62% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (+0.74% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
Advertisement
LIVN and
Correlation & Price change
A.I.dvisor indicates that over the last year, LIVN has been loosely correlated with CRL. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LIVN jumps, then CRL could also see price increases.
| Ticker / NAME | Correlation To LIVN | 1D Price Change % | ||
|---|---|---|---|---|
| LIVN | 100% | -1.59% | ||
| CRL - LIVN | 48% Loosely correlated | +9.33% | ||
| NVST - LIVN | 42% Loosely correlated | +0.96% | ||
| A - LIVN | 41% Loosely correlated | +2.74% | ||
| MTD - LIVN | 39% Loosely correlated | +2.69% | ||
| MMSI - LIVN | 39% Loosely correlated | +0.24% | ||
More | ||||
MMSI and
Correlation & Price change
A.I.dvisor indicates that over the last year, MMSI has been loosely correlated with BSX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if MMSI jumps, then BSX could also see price increases.
| Ticker / NAME | Correlation To MMSI | 1D Price Change % | ||
|---|---|---|---|---|
| MMSI | 100% | +0.24% | ||
| BSX - MMSI | 56% Loosely correlated | -2.35% | ||
| SYK - MMSI | 50% Loosely correlated | -2.23% | ||
| ICUI - MMSI | 50% Loosely correlated | -0.15% | ||
| BDX - MMSI | 44% Loosely correlated | +0.28% | ||
| A - MMSI | 43% Loosely correlated | +2.74% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BEEZ | 35.93 | 0.33 | +0.93% |
| Honeytree U.S. Equity ETF (BEEZ) | |||
| DRES | 29.41 | 0.22 | +0.76% |
| GMO Domestic Resilience ETF (DRES) | |||
| MATE | 32.45 | 0.24 | +0.73% |
| Man Active Trend Enhanced ETF (MATE) | |||
| IYY | 187.83 | 1.09 | +0.58% |
| iShares Dow Jones U.S. ETF (IYY) | |||
| KIO | 9.90 | 0.01 | +0.10% |
| KKR Income OPPORTUNITIES FUND | |||